GERN Q2 2018 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$208,000+19.5% YoY

Gross Profit

-$2M-1075.0% margin

Operating Income

-$7M-3481.7% margin

Net Income

-$7M-3333.7% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-34.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$183M

Total Liabilities

$5M

Stockholders' Equity

$178M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$208,000	$174,000	+19.5%
Gross Profit	-$2M	-$2M	-34.6%
Operating Income	-$7M	-$7M	-7.6%
Net Income	-$7M	-$6M	-8.3%